SHREDDEREX 70 mg x 60 Capsules – Denik Pharm

Description

Denik Pharm SHREDDEREX 70 mg is a premium multi-compound research formulation combining GW-501516 (Cardarine), Andarine (S-4), SR-9009 (Stenabolic), and YK-11 into a single advanced laboratory research product. Engineered for scientists investigating metabolic regulation, androgen receptor biology, nuclear receptor signaling, and skeletal muscle physiology, SHREDDEREX offers a comprehensive platform for studying the interaction of multiple molecular pathways within a single research model.

By integrating compounds with distinct biological targets—including PPAR-δ activation, androgen receptor modulation, REV-ERBα signaling, and myostatin-related research pathways—SHREDDEREX enables researchers to explore the complex relationship between energy metabolism, gene transcription, cellular adaptation, tissue-selective signaling, and musculoskeletal physiology. This multi-target approach makes it an exceptional investigational formulation for advanced endocrine and metabolic research.

Each bottle contains 60 capsules, with a total active content of 70 mg per capsule, manufactured by Denik Pharm under stringent pharmaceutical-quality standards. Every batch undergoes rigorous quality testing to ensure exceptional purity, formulation accuracy, and batch-to-batch consistency for professional laboratory investigations.

Key Features

• Premium four-compound research formulation
• 70 mg total active ingredients per capsule
• 60 capsules per bottle
• Combines GW-501516, Andarine (S-4), SR-9009, and YK-11
• Multiple mechanisms of action for comprehensive research applications
• High-purity laboratory-grade formulation
• Extensively researched in metabolic physiology, androgen receptor biology, and molecular endocrinology
• Suitable for investigations involving PPAR-δ activation, REV-ERBα signaling, androgen receptor modulation, and myostatin-related pathways
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

SHREDDEREX combines four investigational compounds that target complementary biological pathways to provide researchers with a versatile model for studying complex physiological interactions.

• GW-501516 (20 mg) acts as a PPAR-δ receptor agonist, allowing investigation of lipid metabolism, mitochondrial function, and energy homeostasis.
• Andarine (S-4) (20 mg) selectively interacts with androgen receptors, supporting research into tissue-selective signaling and musculoskeletal physiology.
• SR-9009 (20 mg) activates the REV-ERBα nuclear receptor, enabling studies of circadian rhythm regulation, mitochondrial biology, and metabolic gene expression.
• YK-11 (10 mg) is investigated for its interaction with the androgen receptor and its relationship with myostatin (GDF-8) and Follistatin signaling pathways involved in skeletal muscle biology.

Together, these complementary mechanisms provide researchers with an advanced platform for examining endocrine communication, receptor pharmacology, metabolic adaptation, cellular signaling, and gene regulation within integrated biological systems.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredients (Per Capsule):

• GW-501516 (Cardarine) – 20 mg
• Andarine (S-4) – 20 mg
• SR-9009 (Stenabolic) – 20 mg
• YK-11 – 10 mg

Total Active Ingredients: 70 mg per capsule

Packaging: 60 Capsules